BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  MedTest Announces Commercial Availability of Four New Forensic Use Only Urine Drug Screening Reagents to its Broad Test Menu

  MedTest announced the commercial availability of four new “Forensic Use Only” urine drug tests for use on its BS-200, BS-480 and BA-800M Chemistry Analyzers.

  November 13, 2017

   · 

  2 min read
• Bio NC

  TransEnterix Announces Senhance U.S. Sale Agreement With Florida Hospital

  TransEnterix announced that Florida Hospital entered into an agreement to purchase the Company’s Senhance Surgical Robotic System.

  November 13, 2017

   · 

  4 min read
• Business

  SANUWAVE Health to Hold Third Quarter 2017 Financial Results and Business Update Call on Tuesday, November 21, 2017

  The Company will host a conference call on Tuesday, November 21, 2017, beginning at 10:00AM Eastern Time to discuss the third quarter financial results, provide a business update and answer questions.

  November 13, 2017

   · 

  4 min read
• Biotech Beach

  CytRx Corporation Provides Business Update and Announces New Shareholder Initiatives

  CytRx Corporation today provided a business update and announced new shareholder relations initiatives.

  November 13, 2017

   · 

  4 min read
• 

  Deals

  Sawai Pharma Unloads 20% Stake in Its U.S. Subsidiary for $211M

  The transaction is expected to close by the end of March 2018.

  November 13, 2017

   · 

  3 min read
• Pharm Country

  Reliefband, Wearable Technology, Provides Relief to Those With Chronic Motion Sickness

  Reliefband Technologies is the leader in providing neuro-stimulation for the drug-free treatment of nausea.

  November 13, 2017

   · 

  2 min read
• Business

  Innovus Pharma Enters the $11 Billion Glucose Monitoring Market With FDA-Cleared Products via an Expanded Agreement With ACON Laboratories, Inc.

  Innovus Pharma will offer the GlucoGorx Kit, which will provide highly sensitive glucose level testing results within 4 seconds, to its customers who buy its GlucoGorx clinical glucose supplement.

  November 13, 2017

   · 

  5 min read
• Business

  Bruker Announces Quarterly Dividend

  Bruker today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

  November 13, 2017

   · 

  1 min read
• Drug Development

  MabVax Therapeutics to Present Positive Development Study Results Enabling Manufacturing of Two Radionuclide Products for Phase I Clinical Trials at the 2017 AAPS Annual Meeting

  The MVT-1075 Phase I first-in human clinical trial is an open-label, multi-center study evaluating the safety and efficacy in up to 22 patients for patients with locally advanced or metastatic adenocarcinoma of the PDAC or other CA19-9 positive malignancies including colon and lung cancers.

  November 13, 2017

   · 

  5 min read
• Valeant Announces Launch of Private Offering of Add-on Secured Notes

  Valeant announced today that it has launched an offering of $750,000,000 aggregate principal amount of 5.500% senior secured notes due 2025.

  November 13, 2017

   · 

  3 min read